On 7 August 2015 President signed the Law on amendments to the Tax Code regarding transfer pricing adopted by the High Council of Ukraine on 15 July of the same year (Draft Law No.1861). The aforesaid document has clarified certain rules regarding regulation of transfer pricing in Ukraine, in particular the following:
It was determined that business transactions envisaged by subparagraphs 39.2.1.1 - 39.2.1.3 and subparagraph 39.2.1.5 of the paragraph 39.2.1, Article 39 of the Tax Code shall be deemed controlled provided the following conditions are simultaneously met:
Following the amendments to the Tax Code penalty for failure to provide the report on controlled transaction was reduced from 5% to 1% of the amount of undeclared controlled transactions as well as certain technical adjustment was made to procedures determining profitability level of controlled transactions subject to transfer pricing, defining arm's length prices etc.
Moreover, it was stipulated that tax base for delivery of goods/services shall be determined based on contractual value of such goods/services taking into account national taxes and fees (except for charges for mandatory state pension insurance charges collected on the costs of mobile communication services, value-added tax and excise tax on ethyl alcohol used by manufacturing business entities for production of pharmaceutical products including blood components and preparations made of blood components (excepting pharmaceutical products in the form of balms and elixirs).
The event focused on the transformation of Ukraine's intellectual property sector on its path toward European integration.
Improving access to safe and affordable medicines for the Ukrainian population is one of the Government of Ukraine's top priorities. SAFEMed Activity (2017-2025) has supported this effort by appIying health system strengthening best practices.
The Ministry of Health website has posted a notice about the release of a revised draft order of the Ministry of Health ‘On Approval of Amendments to Certain Re
On 25 September, a webinar was held on the topic: ‘180 days of new drug price regulation. Results, prospects and practical advice.’ The event was organized by LA Law Firm in partnership with Proxima Research International.